Table 3.
Overall | HA combined | Monophasic HA | Biphasic HA | Collagen | Mesoglow | IAL-systems | Autologous fat | |
---|---|---|---|---|---|---|---|---|
2 weeks | 3.21 [3.11–3.32] | 3.21 [3.11–3.32] | 3.28 [3.13–3.43] | 3.15 [3.01–3.3] | ||||
I2 | 71% | 71% | 74% | 76% | ||||
No of studies | 3 | 3 | 2 | 2 | 0 | 0 | 0 | 0 |
1 month | 2.21 [2.14–2.28] | 2.86 [2.55–3.17] | 2.9 [2.53–3.28] | 2.77 [2.21–3.34] | 2.08 [1.97–2.19] | 2.03 [1.93–2.14] | 3 [2.8–3.2] | |
I2 | 94% | 0% | 0% | NA | 88% | 86% | NA | |
No of studies | 4 | 2 | 2 | 1 | 0 | 1 | 1 | 1 |
2 months | 2.47 [2.43–2.52] | 2.65 [2.58–2.71] | 2.63 [2.51–2.74] | 2.66 [2.58–2.74] | 1.75 [1.6–1.9] | 1.75 [1.61–1.89] | ||
I2 | 97% | 74% | 0% | 87% | NA | NA | ||
No of studies | 5 | 4 | 2 | 3 | 0 | 1 | 1 | 0 |
3 months | 2.32 [2.21–2.44] | 2.01 [1.68–2.33] | 2.01 [1.68–2.33] | 2.37 [2.25–2.5] | ||||
I2 | 90% | 96% | 96% | 0% | ||||
No of studies | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 |
4 months | 2.24 [2.2–2.29] | 2.34 [2.28–2.4] | 2.51 [2.39–2.63] | 2.27 [2.2–2.35] | 1.4 [1.23–1.57] | 1.4 [1.25–1.56] | ||
I2 | 98% | 98% | 50% | 98% | NA | NA | ||
No of studies | 6 | 5 | 2 | 4 | 0 | 1 | 1 | 0 |
5 months | 2.78 [2.6–2.96] | |||||||
I2 | NA | |||||||
No of studies | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
6 months | 2.32 [2.26–2.37] | 2.35 [2.29–2.42] | 2.36 [2.22–2.5] | 2.35 [2.28–2.43] | 2.08 [1.93–2.24] | |||
I2 | 93% | 95% | NA | 96% | 0% | |||
No of studies | 5 | 4 | 1 | 4 | 1 | 0 | 0 | 0 |
9 months | 1.68 [1.52–1.83] | 1.68 [1.52–1.83] | ||||||
I2 | 0% | 0% | ||||||
No of studies | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
12 months | 1.27 [1.12–1.42] | 1.27 [1.12–1.42] | ||||||
I2 | 0% | 0% | ||||||
No of studies | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
NA—not applicable